Recombinant Human ATG4A Protein，His

ATG4A, or autophagy-related 4A, is a vital cysteine protease that plays a crucial role in the autophagy process, which is essential for cellular homeostasis, degradation of damaged organelles, and response to stress. This protein is one of the key regulators of the autophagic pathway, primarily responsible for the processing of LC3 (microtubule-associated protein 1 light chain 3), a pivotal marker for autophagosome formation. In recent years, research has highlighted the significance of ATG4A in various physiological and pathological contexts, including cancer, neurodegenerative diseases, and infections. Dysregulation of autophagy has been implicated in multiple diseases, making ATG4A a potential therapeutic target. An understanding of the structure and function of ATG4A is essential, as it could provide insights into the mechanisms underlying autophagy and its impact on health and disease. The recombinant expression of ATG4A allows researchers to study its activity, determine its enzymatic properties, and explore the molecular mechanisms governing its interaction with substrates and other autophagy-related proteins. By characterizing ATG4A, scientists aim to unravel its role in cellular processes and its potential as a drug target, thus contributing to the development of innovative strategies for treating autophagy-related diseases. This research area is particularly exciting due to the growing recognition of autophagy's role in aging and various diseases, making ATG4A a focal point for advancing therapeutic interventions and improving our understanding of cellular dynamics.